Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model
Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper
Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper
View: Text | PDF
Research Article Cardiology Genetics

Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model

  • Text
  • PDF
Abstract

Myotonic dystrophy type 1 (DM1) is caused by an expanded CTG repeat in the DMPK gene, resulting in mutant transcripts that form expanded CUG (CUGexp) RNA foci and sequester muscleblind-like (MBNL) RNA-binding proteins. DM1 is multisystemic, with progressive worsening of disease manifestations in affected tissues. Disease progression is attributed to somatic expansion of the CTG repeats with age, resulting in production of CUGexp RNA with enhanced intrinsic toxicity due to increased MBNL sequestration. To determine the degree to which cardiac disease progression can occur independently of repeat expansion, we used a transgenic DM1 mouse model with inducible heart-specific expression of a stable, interrupted 960-CUG-repeat RNA. Sustained CUGexp RNA expression caused progressive cardiac enlargement, contractile dysfunction, conduction delay, myocardial fibrosis, and reduced survival, while MBNL-dependent splicing defects remained static, consistent with the stable repeat length. We also determined the degree of reversibility after different periods of CUGexp RNA expression by shutting off the repeat-containing transgene. Suppression of CUGexp RNA expression rescued cardiac abnormalities, but reversibility declined with longer exposure to the toxic RNA. These findings demonstrate that prolonged expression of stable CUGexp RNA drives progressive cardiac pathology, revealing a mechanism of disease progression in DM1 in addition to somatic expansion.

Authors

Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper

×

Figure 3

Long-term CUGexp RNA expression resulted in progressive prolongation of cardiac conduction intervals and increased prevalence of abnormal cardiac rhythms.

Options: View larger image (or click on image) Download as PowerPoint
Long-term CUGexp RNA expression resulted in progressive prolongation of ...
Prospective measurements of (A) QRS, (B) QTc, and (C) PR intervals were determined by surface ECG recordings in CUG960 +dox and MHCrtTA +dox control mice at 2, 8, 14 months of age. Data represent the mean ± SEM and were analyzed using 2-way ANOVA followed by Tukey’s multiple-comparison test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. (D) Numbers of animals per sex showing intraventricular conduction delay (IVCD) on surface ECG tracings. (E) Representative ECG tracings showing arrhythmias frequently observed in the CUG960 +dox mice. Split QRS complex indicating bundle branch block and IVCD was observed in all mice shown in panels 1–5. Abnormalities include premature ventricular contraction (PVC; panels 1 and 2), sustained ventricular tachycardia (VT; panel 3), third-degree atrioventricular block (complete heart block; panel 4), and non-sustained ventricular tachycardia (NSVT; panel 5). Images were taken from lead I (left arm to right arm) after high-pass filter (cutoff frequency: 5 Hz) were applied. (F) Kaplan-Meier survival analysis showed a reduced lifespan in CUG960 +dox mice, especially in male mice with CUGexp RNA expression. The log-rank (Mantel-Cox) test showed that survival curves were significantly different, with a P value of 0.0299. MHCrtTA+dox cohort: n = 20 (11 males and 9 females). CUG960 +dox cohort: n = 21 (10 males and 11 females). Males (blue symbols) and females (purple symbols) are indicated.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts